Nuveen’s Anixa Biosciences ANIX Stock Holding History

Nuveen’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.08K	Buy	+728	New	+$2.34K	﹤0.01%	4844

Other funds holding ANIX

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

First Affirmative Financial Network Colorado Springs, Colorado $456M AUM

Gemmer Asset Management Walnut Creek, California $1.53B AUM 31.12% 1-Year Est. Return

Nuveen's ANIX Position: Q3 2026 in Review

Nuveen opened a new position in Anixa Biosciences (ANIX) in Q3 2026: 728 shares worth $2.08K. The stake represents ﹤0.01% of the portfolio and ranks #4844 among its holdings.

31 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

Nuveen held 728 shares of Anixa Biosciences worth $2.08K as of Q3 2026.
Anixa Biosciences was a new Nuveen position in Q3 2026.
Anixa Biosciences made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4844 holding.
31 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.